Biotech’s D&O Litigation Surge: Navigating The Turbulent Landscape

 
• By Justin Kozak

The biotech industry faces a surge in litigation due to stricter regulations and patent disputes. This legal storm challenges companies and investors, but there are proactive strategies for mitigating risk in this dynamic landscape.

Judge Gavel, Stethoscope, Scale Of Justice, Many Pills And Law Books On Wooden Table. Medica

More from Business Strategy

More from In Vivo